Records containing: Vaccines
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23A Prospective, Single-arm, Open-label, Non-interventional, Multicenter to Assess the Safety of BNT162b2 in Domestic Post-marketing Surveillance
-
CLINICAL_TRIALS study record update · 2026-02-23A PHASE 1, RANDOMIZED, OBSERVER-BLIND, DOSE-RANGING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST PANDEMIC INFLUENZA IN HEALTHY ADULTS
-
CLINICAL_TRIALS study record update · 2026-02-11The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age
-
CLINICAL_TRIALS study record update · 2025-12-12Increasing Men's Engagement in Preventive Healthcare Through an Enhanced Cocoon Vaccination Strategy
-
CLINICAL_TRIALS study record update · 2025-12-03The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-16Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
-
CLINICAL_TRIALS study record update · 2025-05-11A Phase 2, Open-label, Study to Evaluate the Safety and Immunogenicity of a Heterologous 2-dose Vaccination Regimen Using Ad26.ZEBOV, MVA-BN-Filo in Adults and Children Originally Enrolled in the Control Arm of the EBOVAC-Salone Study
-
CLINICAL_TRIALS study record update · 2025-02-11A Multifaceted Intervention on Reducing Immunization Errors: a Pragmatic, Stepped-wedge, Cluster Randomized Trial
-
CLINICAL_TRIALS study record update · 2024-12-09Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up
-
CLINICAL_TRIALS study record update · 2024-12-05Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake
-
CLINICAL_TRIALS study record update · 2024-12-05Effects of Prompt to Bundle COVID-19 Booster and Flu Shot
-
CLINICAL_TRIALS study record update · 2024-11-15A Phase III Multinational, Multicenter, Observer-Blinded, Randomized, Active-Controlled Trial to Evaluate the Immunogenicity and Safety of the Preventive COVID-19 Vaccine AdCLD-CoV19-1 OMI Administered As a Booster to Adults Aged 19 Years Old and Above
-
CLINICAL_TRIALS study record update · 2024-07-17A Phase I/II (Single Center, Open, Phase I and Multicenter, Double-Blinded, Randomized, Placebo-Controlled, Phase II) Trial to Evaluate the Safety and Immunogenicity of the AdCLD-CoV19-1 OMI Administered as a Booster to Healthy Adults Aged 19 Years Old and Above
-
CLINICAL_TRIALS study record update · 2024-02-14Study on the Impact of Coordinated Immunizations Against RSV and Influenza on the Prognosis in Patients With Chronic Heart Failure.
-
CLINICAL_TRIALS study record update · 2024-02-07Phase 2, Randomized, Double-blind Study to Evaluate Immunogenicity Superiority of a Booster Dose With an Omicron or a Trivalent Vaccine Compared to CoronaVac, in Adults Immunized With Different Vaccine Schedules Against SARS-CoV-2 in Chile
-
CLINICAL_TRIALS study record update · 2023-06-22A Phase IIb, Multicenter, Observer-Blinded, Randomized, Placebo-Controlled Trial to Evaluate the Immunogenicity and Safety of the AdCLD-CoV19-1 in Healthy Adults Aged 19 Years Old and Above
-
CLINICAL_TRIALS study record update · 2023-02-03Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks
-
CLINICAL_TRIALS study record update · 2023-02-02Multicenter, Phase 3, Randomized Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against SARS-CoV-2 Infection in Adults.
-
CLINICAL_TRIALS study record update · 2022-08-09A Phase III, Randomized, Double-blind and Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Influenza Vaccine, Inactivated, Quadrivalent Developed by Sinovac Biotech Co., Ltd. Compared to a Licensed Quadrivalent Influenza Vaccine, VaxigripTetra™, in Individuals Aged 3 Years and Older in Chile
-
CLINICAL_TRIALS study record update · 2022-07-22Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
-
CLINICAL_TRIALS study record update · 2022-07-14Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women During the 2nd - 3rd Trimester
-
CLINICAL_TRIALS study record update · 2022-06-02Simple Blind, Placebo Controlled, Randomized Safety and Reactogenicity Trial of "Baby-Hib [Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b], Lyophilizate for Preparation of Intramuscular Injection Solution, 0.5 mL/Dose", FSUE SPbSRIVS FMBA of Russia, in Volunteers Aged 18-50
-
CLINICAL_TRIALS study record update · 2021-11-17Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
-
CLINICAL_TRIALS study record update · 2021-10-20Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)
-
CLINICAL_TRIALS study record update · 2021-05-27Enhancing HPV Vaccination Rates for 11-14 Year Old Adolescents Using New York State's Immunization Information System